Your drug development solution provider

R&D Personalized medicine: DYNAPRED – DynaPred

Dynakin R&D activity is mainly directed towards individualized treatment systems through the development of methods and products for prediction of the optimal dose, or posology scheme, for drugs with a narrow therapeutic range mostly in chronic or costly therapies and in pediatrics.

DynaPRED® is an application designed to be accessible on a server via the web with a mathematical estimation core (stand alone proprietary executable and dynamically loaded library). DynaPRED is the Bayesian estimator functionality of Dynakin’s own development of a maximum likelihood estimation software package for PK /PD, Dknonlin®. Dknonlin – DynaPRED has been optimized to perform real-time estimation offering the possibility of fully interactive screen (touch screen) for trial and error / simulation exploration of dosing regimen scenaria.

Funded project Spanish Government #SME-2017-1008-1 (The platform for personalized pharmacotherapy).

Funded project CDTI #INNO-20171110 (Development of a platform to streamline dosing regimens in older adults in cooperation with the University of Florida).

logo mineco
Logo Union Europea

Seeking consultation for drug development

Contact us

We wish to know from you,
we wish to help you.

I accept the terms of use.